First human tests begin for new drug combination
NCT ID NCT07202663
Summary
This is an early safety study testing a new drug called BB-025, both by itself and after another drug called BB-031. The main goal is to see how safe these drugs are and how they move through the body in 72 healthy volunteers. Participants will be monitored for 28 days to check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Scintia Clinical Research Ltd
RECRUITINGRandwick, New South Wales, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.